ArticleThe American journal of case reports2026
Giant Retroperitoneal Liposarcoma Without Organ Invasion: A Rare Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Retroperitoneal liposarcoma is a malignant soft tissue sarcoma arising from adipocyte precursors, with an incidence of 3-4 cases per million. Giant retroperitoneal tumors pose significant surgical challenges due to their size and proximity to vital structures. CASE REPORT We report the case of a 61-year-old woman who presented with progressive abdominal distension, mild discomfort, nausea, dyspepsia, and exertional dyspnea. Preoperative MRI revealed a giant retroperitoneal mass (28×23.6×24 cm) with heterogeneous adipose and non-lipomatous components, initially suggestive of dedifferentiated liposarcoma. However, ultrasound-guided core needle biopsy revealed histopathological findings consistent with well-differentiated liposarcoma (WDLPS). Complete surgical excision via midline laparotomy was performed; the tumor weighed 10 kg. Despite the massive tumor size, complete tumor removal was achieved while preserving adjacent organs, without the need for multivisceral resection. Histopathological examination was consistent with WDLPS with negative margins (R0), no vascular invasion (V0); staged pT4. Postoperative MRI, whole-body scintigraphy, and PET/CT showed no residual or metastatic disease. No adjuvant therapy was administered, and at 3-month short-term follow-up, there was no evidence of residual or recurrent disease. CONCLUSIONS This case suggests the feasibility of complete surgical excision with organ preservation in selected cases of giant retroperitoneal liposarcoma with clear dissection planes. It also underscores the role of preoperative imaging and core needle biopsy in diagnostic evaluation and surgical planning. Surgery remains the standard treatment, while the role of adjuvant therapy depends on histological subtype. Longer follow-up is required to assess long-term oncologic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.